GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX20
|
ENSG00000164532.10 | T-box transcription factor 20 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_57662419 | 45.97 |
ENST00000388812.4
ENST00000538815.1 ENST00000456916.1 ENST00000567154.1 ENST00000388813.5 ENST00000562558.1 ENST00000566271.2 |
GPR56
|
G protein-coupled receptor 56 |
chr6_-_2842087 | 11.62 |
ENST00000537185.1
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
chr6_-_2842219 | 8.15 |
ENST00000380739.5
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
chr17_-_3599327 | 8.10 |
ENST00000551178.1
ENST00000552276.1 ENST00000547178.1 |
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr3_-_131221790 | 7.54 |
ENST00000512877.1
ENST00000264995.3 ENST00000511168.1 ENST00000425847.2 |
MRPL3
|
mitochondrial ribosomal protein L3 |
chr17_-_3599492 | 7.44 |
ENST00000435558.1
ENST00000345901.3 |
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chrX_-_100872911 | 6.18 |
ENST00000361910.4
ENST00000539247.1 ENST00000538627.1 |
ARMCX6
|
armadillo repeat containing, X-linked 6 |
chr7_-_139763521 | 6.15 |
ENST00000263549.3
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr17_-_3599696 | 5.99 |
ENST00000225328.5
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr1_+_43824669 | 4.82 |
ENST00000372462.1
|
CDC20
|
cell division cycle 20 |
chr2_-_219134343 | 4.64 |
ENST00000447885.1
ENST00000420660.1 |
AAMP
|
angio-associated, migratory cell protein |
chr19_-_4540486 | 4.60 |
ENST00000306390.6
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1 |
chr5_+_135394840 | 4.14 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr6_-_90062543 | 3.97 |
ENST00000435041.2
|
UBE2J1
|
ubiquitin-conjugating enzyme E2, J1 |
chr17_-_7080227 | 3.95 |
ENST00000574330.1
|
ASGR1
|
asialoglycoprotein receptor 1 |
chr2_-_219134822 | 3.90 |
ENST00000444053.1
ENST00000248450.4 |
AAMP
|
angio-associated, migratory cell protein |
chr2_+_207630081 | 3.82 |
ENST00000236980.6
ENST00000418289.1 ENST00000402774.3 ENST00000403094.3 |
FASTKD2
|
FAST kinase domains 2 |
chr1_-_11118896 | 3.69 |
ENST00000465788.1
|
SRM
|
spermidine synthase |
chr11_-_14358620 | 3.69 |
ENST00000531421.1
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
chr2_+_64068074 | 3.43 |
ENST00000394417.2
ENST00000484142.1 ENST00000482668.1 ENST00000467648.2 |
UGP2
|
UDP-glucose pyrophosphorylase 2 |
chr3_+_142315225 | 3.39 |
ENST00000457734.2
ENST00000483373.1 ENST00000475296.1 ENST00000495744.1 ENST00000476044.1 ENST00000461644.1 |
PLS1
|
plastin 1 |
chr12_-_56123444 | 2.81 |
ENST00000546457.1
ENST00000549117.1 |
CD63
|
CD63 molecule |
chr16_+_31044812 | 2.80 |
ENST00000313843.3
|
STX4
|
syntaxin 4 |
chr1_-_154909329 | 2.24 |
ENST00000368467.3
|
PMVK
|
phosphomevalonate kinase |
chr15_-_22448819 | 2.07 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr10_+_114135004 | 2.03 |
ENST00000393081.1
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
chr14_-_106453155 | 1.96 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
chr1_-_17380630 | 1.89 |
ENST00000375499.3
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
chr1_-_158300747 | 1.68 |
ENST00000451207.1
|
CD1B
|
CD1b molecule |
chr2_+_61108650 | 1.65 |
ENST00000295025.8
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr1_+_87797351 | 1.64 |
ENST00000370542.1
|
LMO4
|
LIM domain only 4 |
chr12_+_15475331 | 1.58 |
ENST00000281171.4
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
chr8_+_27182862 | 1.28 |
ENST00000521164.1
ENST00000346049.5 |
PTK2B
|
protein tyrosine kinase 2 beta |
chr8_+_27183033 | 1.21 |
ENST00000420218.2
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr12_+_15475462 | 1.16 |
ENST00000543886.1
ENST00000348962.2 |
PTPRO
|
protein tyrosine phosphatase, receptor type, O |
chr5_+_133861339 | 1.05 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
chr4_-_26492076 | 1.01 |
ENST00000295589.3
|
CCKAR
|
cholecystokinin A receptor |
chr10_+_114135952 | 0.99 |
ENST00000356116.1
ENST00000433418.1 ENST00000354273.4 |
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
chr12_-_121477039 | 0.90 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr22_+_38219389 | 0.88 |
ENST00000249041.2
|
GALR3
|
galanin receptor 3 |
chr1_+_147013182 | 0.86 |
ENST00000234739.3
|
BCL9
|
B-cell CLL/lymphoma 9 |
chr12_-_121476750 | 0.81 |
ENST00000543677.1
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr12_-_121476959 | 0.80 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr2_+_61108771 | 0.73 |
ENST00000394479.3
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
chr14_+_77228532 | 0.67 |
ENST00000167106.4
ENST00000554237.1 |
VASH1
|
vasohibin 1 |
chr15_-_38519066 | 0.61 |
ENST00000561320.1
ENST00000561161.1 |
RP11-346D14.1
|
RP11-346D14.1 |
chrX_+_78200913 | 0.43 |
ENST00000171757.2
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
chrX_+_78200829 | 0.39 |
ENST00000544091.1
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
chr15_-_74504560 | 0.37 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
chr15_-_74504597 | 0.29 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
chr1_+_162760513 | 0.21 |
ENST00000367915.1
ENST00000367917.3 ENST00000254521.3 ENST00000367913.1 |
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7 |
chr22_-_46283597 | 0.11 |
ENST00000451118.1
|
WI2-85898F10.1
|
WI2-85898F10.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.9 | 2.7 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.8 | 3.8 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.7 | 2.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.7 | 22.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.7 | 3.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.7 | 3.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.6 | 2.5 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.6 | 4.0 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.5 | 3.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 4.8 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.2 | 0.7 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 2.8 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 1.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 2.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 4.6 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 1.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 1.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.7 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.1 | 3.0 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.1 | 8.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 7.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
0.1 | 4.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 19.8 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 2.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 2.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 3.2 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 0.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 3.7 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 2.0 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 21.5 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.6 | 3.4 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 1.9 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 2.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 8.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 2.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 2.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 7.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 2.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 4.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 3.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 4.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 19.8 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 2.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 4.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 3.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 2.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 21.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.2 | 3.7 | GO:0004766 | spermidine synthase activity(GO:0004766) |
1.1 | 3.4 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
1.0 | 1.0 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.8 | 2.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 4.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 2.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 1.9 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.5 | 4.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 2.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 6.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 19.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.7 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.2 | 3.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 2.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 4.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 4.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 8.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 4.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 3.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 2.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.8 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 7.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 2.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 2.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 3.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.7 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 1.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 2.0 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 3.7 | GO:0003924 | GTPase activity(GO:0003924) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 18.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 2.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 4.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 3.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 3.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 2.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 2.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 4.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 2.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 2.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 4.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 2.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |